Or. Admin. R. 855-080-0022
Schedule II consists of the drugs and other substances by whatever official, common, usual, chemical, or brand name designated, listed in 21 CFR 1308.12 (v. 04/01/2025) and any quantity of methamphetamine, when in the form of a FDA approved product containing methamphetamine, its salts, isomers, and salts of its isomers as an active ingredient for the purposes of currently accepted medical use.
[Publications: Publications referenced are available for review at the agency.]
ORS 689.205
ORS 475.005, ORS 475.035, ORS 475.055 & ORS 475.065
BP 6-2026, amend filed 06/17/2026, effective 06/17/2026
BP 3-2025, amend filed 06/16/2025, effective 06/16/2025
BP 57-2024, amend filed 06/18/2024, effective 06/20/2024
BP 10-2023, amend filed 06/13/2023, effective 06/13/2023
BP 27-2022, amend filed 06/15/2022, effective 06/16/2022
BP 20-2021, amend filed 06/15/2021, effective 06/15/2021
BP 10-2017, amend filed 12/22/2017, effective 12/26/2017
BP 10-2014, f. 12-30-14, cert. ef. 1-1-15
BP 8-2010, f. & cert. ef. 6-29-10
BP 1-2007, f. & cert. ef. 6-29-07
BP 4-2006, f. 6-9-06, cert. ef. 7-1-06
BP 4-2000, f. & cert. ef. 2-16-00
Reverted to PB 1-1997, f. & cert. ef. 9-22-97
BP 3-1999(Temp), f. & cert. ef. 8-9-99 thru 1-17-00
PB 1-1997, f. & cert. ef. 9-22-97
PB 1-1996, f. & cert. ef. 4-5-96
PB 1-1994, f. & cert. ef. 2-2-94
PB 1-1992, f. & cert. ef. 1-31-92 (and corrected 2-7-92)
PB 5-1991, f. & cert. ef. 9-19-91
PB 9-1990, f. & cert. ef. 12-5-90
PB 15-1989, f. & cert. ef. 12-26-89
PB 10-1987, f. & ef. 12-8-87
PB 8-1987, f. & ef. 9-30-87
PB 4-1987, f. & ef. 3-30-87